Trasylol News Archive

 

The Trasylol Story Illustrates Why FDA Preemption is Bad Public Policy

-TortDeform
07/03/2008- The crux of the argument that FDA approval of a drug should preempt state lawsuits over that drug is that it should be experts at the FDA who decide whether a drug is safe and what warnings that drug’s label should carry. More>>>

Trasylol "Devastating"

-Lawyers and Settlements
06/17/2008- Because Trasylol was approved so long ago, there are many people whose loved ones were affected by the drug but do not realize it. Barbara S. says her husband, Carson, had open heart surgery in 1998, but she is only now realizing that his serious health problems may have been caused by Trasylol. More>>>

Trasylol: Pivotal Study Could Have Happened Sooner
-LawyersandSettlements.com
06/08/2008- New York, NY: One of the lead authors of a pivotal Canadian study that most experts say will spell the end of Trasylol, has suggested that Bayer AG could have undertaken a similar study ten years ago. In that time, thousands have died. More>>>

Trasylol Recall Too Late For Many Patients

-Lawyers and Settlements
05/30/2008- Earlier this month, Bayer announced that it was recalling remaining Trasylol stocks from the US market. The move comes after repeated studies found that patients given Trasylol during open heart surgery had a higher risk of kidney failure. More>>>

End for Anti Bleeding Drug, Trasylol
-InjuryBoard.com
05/28/2008- In November of 2007, after initial reports were given to the Food & Drug Administration (FDA) Bayer AG, the maker of the drug Trasylol (also know as aprotinin), agreed to temporarily suspend sales and marketing of Trasylol. More>>>

It's Game Over for Trasylol, but Bayer Refuses to Fold
-LawyersandSettlements.com
05/26/2008- Washington, DC: If Trasylol maker Bayer AG were into playing the odds, the Germany-based manufacturer is hedging its bets over its once-dominant anti-bleeding drug, even though most believe that the Canadian BART clinical trial has effectively sounded the death knell for a drug that has allegedly spelled death for thousands of heart patients. More>>>

Remaining Trasylol Stocks Recalled
-LawyersandSettlements.com

Danger From Heart Surgery Drug Confirmed
-Washington Post
05/22/2008- A new Canadian study confirms that people given Trasylol, a drug used to reduce bleeding during heart surgery, face a 53 percent increased risk of death. More>>>

BART Closes the Book on Aprotinin 

-Medscape
05/21/2008- Results of the Blood Conservation Using Antifibrinolytics in a Randomized Trial (BART), halted by the company [Bayer] last year, have now been published online May 15, 2008 in the New England Journal of Medicine, scheduled for its May 29, 2008 issue, confirming that aprotinin (Trasylol, Bayer Healthcare Pharmaceuticals), an antifibrinolytic agent designed to reduce major bleeding during coronary artery bypass graft (CABG), significantly increased the risk of death. More>>>

Could This Be the Final Nail in the Coffin for Trasylol?

Bayer pulls US Trasylol supplies after study
-Reuters
05/17/2008- BOSTON, May 14 (Reuters) - Bayer AG is removing remaining supplies of its heart-surgery drug Trasylol from the U.S. market after a long-awaited study found it raised the risk of death compared to two alternatives, U.S. regulators said on Wednesday. More>>>

Bayer Will Begin Pulling Remaining Stock of Trasylol
-Bloomberg.com
05/16/2008- Bayer AG will begin removing the remaining stock of the drug Trasylol, used to control bleeding, from warehouses and hospitals, the U.S. Food and Drug Administration said in a statement today. More>>>

Study Confirms Trasylol Dangers
-InjuryBoard.com
05/16/2008- The results of a study published in the New England Journal of Medicine have confirmed preliminary findings that Bayer’s anti-bleeding medication Trasylol (aprotinin) dramatically increases a patient’s risk of death. More>>>

Trasylol Gone for Good
-NewsInferno.com
05/16/2008- Trasylol is being removed from the market for good. Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart surgery, in November, after a clinical trial found patients treated with Trasylol were dying at higher rates than others. More>>>

Bayer anti-bleeding drug linked to 50 per cent higher death rate than alternatives
-Orillia Packet & Times
05/16/2008- An expensive drug used to minimize severe bleeding during heart surgery actually significantly increased the risk that patients would die during surgery or in the 30 days following, a Canadian study comparing the drug to two far cheaper alternatives shows. More>>>

Is this the end of the Trasylol story?
-FiercePharma
05/15/2008 - A new study could be the last nail in Trasylol's coffin. In a head-to-head comparison of Trasylol (aprotinin) and two other anti-bleeding meds, patients getting Trasylol during heart surgery were much more likely to die than patients on the other meds. More>>>

Study likely spells end for anti-bleeding drug

-Washington Post
05/15/2008 - An anti-bleeding drug probably will stay off the market, experts say, after a rigorous study found patients getting the medication during heart surgery were much more likely to die than patients given other drugs. More>>>

Patients given popular heart surgery drug had higher risk of dying: study

-The Ottawa Citizen
05/15/2008 - Patients who received a drug commonly used to control bleeding during heart surgery were at a higher risk of dying, new research by the Ottawa Health Research Institute reveals. More>>>

Trasylol Tragedy Timeline: The Dates of Destiny

-Lawyers and Settlements
05/12/2008 - The tragedy that is Trasylol and the scores of people who have died at the hands of the expensive anti-bleeding drug reads like the plot line of a bad movie. Only in this case, the villain doesn't get it in the end. At least, not yet. That payback may eventually be found in the courts of law as hundreds of lawsuits move forward. More>>>

Trasylol: "I've Gone Through Hell"

-Lawyers and Settlements
05/09/2008 - Loretta M. says she is sure she was given Trasylol during her open heart surgeries because her doctor spoke about using blood-regulating drugs during surgery. More>>>

Trasylol Death Unnecessary
-Lawyers and Settlements
05/04/2008- Although Trasylol has been recalled, many people are only now realizing that they or their loved ones may have been given the drug during open heart surgery and may have suffered serious adverse reactions to the drug, including kidney failure. More>>>

Trasylol May Have Caused Advanced Kidney Failure
-Lawyers and Settlements
04/29/2008 - Mark L. suffered kidney failure shortly after his open heart surgery. However, he does not know for sure if Trasylol was used. Mark is now trying to determine whether or not doctors gave him Trasylol to stop him from bleeding during surgery. More>>>

Massive side effects of TRASYLOL known for a Long Time
-LawyersandSettlements.com
04/24/2008- The medical doctor Professor Dr. Juergen H. Fischer already gave warnings during the 1980's concerning the dangers of TRASYLOL. However, no action was taken. We interviewed Prof. Fischer about the long career of a sometimes deadly drug. More>>>

Lawsuits seek damages from Bayer over anti-bleeding drug

-Miami Herald
04/23/2008 - Eight lawsuits filed in a Florida federal court are seeking damages from Bayer AG over a controversial anti-bleeding drug. More>>>

Heart Drug Trasylol Pulled From Market After 50 Percent Increase in Death Rate Discovered

-Natural News
04/20/2008 - Pharmaceutical giant Bayer AG has announced that it is withdrawing its drug Trasylol from the market in response to a request by the FDA, in the face of increasing evidence that the drug increases patients' risk of death. More>>>

Questions about Trasylol Since 1963
LawyersandSettlements.com
04/20/2008- Cologne, Germany: When Bayer AG convenes its annual stockholder's meeting on April 25th in Cologne, the German group Coalition against BAYER Dangers (CBG) will be on hand to introduce countermotions to the proceedings, one of which will focus on the history, and dangers of Trasylol (known as Aprotinin). More>>>

Trasylol: “What the Hell Did They Give These People?”
-LawyersandSettlements.com

New Trasylol Trial Halted Due to Deaths
LawyersandSettlements.com
03/29/2008-Washington, DC: On March 27, 2008 Bayer AG said that a new trial on Trasylol had to be halted because the risk of death increased due to excessive bleeding. In addition to this new trial, previous studies have shown that Trasylol has a strong link to kidney failure in patients administered the drug when undergoing heart bypass surgery. More>>>

Protect consumers' right to sue drugmaker
Philadelphia Inquirer
03/14/2008 - Can you imagine what would happen if three jumbo jets crashed in one month? A thousand people dead. Uproar at the FAA. Planes grounded. Immediate comprehensive inspections of all aircraft. Congressional hearings and investigations. Everything possible would be done to immediately assure public safety. More>>>

Congress Hears Warnings about FDA
-consumer affairs
02/27/2008 - Congress got an earful today as it held hearings on legislation that would provide more funding and authority to the Food and Drug Administration (FDA). Consumer and industry groups said the agency is falling short in its mission to ensure the safety of drug and food products More>>>

Trasylol Linked to Over 20,000 Deaths
-Houston.Injuryboard.com
02/26/2008 —A recent study found that patients that received Bayer's Trasylol during heart surgery were significantly more likely to die within the next decade. Another study of 78,000 patients, originally withheld by Bayer, found a 78 percent increased risk of death within a week following the surgery. More>>>

Trasylol Linked to Death and Kidney Problems Following Surgery
-galvestonbay.injuryboard.com
02/26/2008 —Two studies published in the New England Journal of Medicine have linked the drug Trasylol, used to reduce bleeding during open-heart surgery, to an increased risk of death and kidney damage among other concerns. More>>>

Bayer’s Trasylol Poses Higher Death Risk Among Patients, Studies Say
-enews20.com
02/21/2008 —Two recent U. S. studies reinforced the already existing claims that the Bayer AG’s clotting drug Trasylol poses a deadly risk on heart surgery patients. More>>>

One Thousand Lives A Month
-CBS
02/17/2008 —This is the story of a drug that was on the market for 14 years and may have contributed to the deaths of thousands of patients. Trasylol, made by Bayer, is given in the operating room to control bleeding. It was a big money maker. More>>>

Researcher: FDA Was Too Slow On Trasylol
-CBS
02/15/2008 — A renowned researcher calculates that 22,000 patients could have been saved if the Food and Drug Administration removed the heart surgery drug Trasylol two years ago, when his study revealed widespread death associated with it. More>>>

22,000 died amid delayed Bayer drug recall: doctor
-Reuters
02/15/2008 —The lives of 22,000 patients could have been saved if U.S. regulators had been quicker to remove a Bayer AG drug used to stem bleeding during open heart surgery, according to a medical researcher interviewed by CBS Television's 60 Minutes program. More>>>

Aprotinin safe in on-pump CABG, but not off-pump (with ACE inhibitors)
-TheHeart.org
02/11/2008 - A new retrospective analysis of patients undergoing CABG in whom the antifibrinolytic aprotinin (Trasylol, Bayer) was used has found that the product appears to be safe during on-pump CABG surgery. More>>>

Aprotinin (Trasylol) Kidney Risk Linked to Off-Pump Bypass Plus ACE Inhibitors
-MedPage Today
02/11/2008 - The risk of renal dysfunction after aprotinin (Trasylol) was used during heart surgery appears limited to patients also given ACE inhibitors during an off-pump bypass, suggested a retrospective analysis here. More>>>

Bayer's Trasylol Safe in Some Surgeries, Study Says
-Bloomberg
02/08/2008 - Bayer AG's Trasylol, an anti-bleeding drug that was pulled off the market last year, is safe when used during a certain type of cardiac surgery, researchers said. More>>>

Aprotinin and Ace Inhibitors During Off-Pump Cardiac Surgery Associated with Postoperative Renal Dysfunction
-PharmaLive
02/07/2008 - The blood saving-drug aprotinin appears safe during on-pump cardiac surgery. However, the combination of aprotinin and angiotensin-converting enzyme (ACE) inhibitors during off-pump cardiac surgery is associated with a significant risk of postoperative renal dysfunction. These are the conclusions of authors of an Article published in this week’s edition of The Lancet. More>>>

Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of Trasylol side effects. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. For more information about a Trasylol lawsuit, a possible Trasylol recall, or for questions regarding Trasylol class action lawsuits fill out our free Trasylol case evaluation . Our on-staff nurse and attorneys are standing by to answer any questions you may have regarding Trasylol side effects, a possible Trasylol class action lawsuit, or any other type of Trasylol litigation.